[c09aa8]: / clusters / ordered9kclusters / clust_1464.txt

Download this file

82 lines (81 with data), 4.9 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
Adequate organ function as defined per protocol
Demonstrate adequate organ function as defined below:
Adequate organ function as defined below:
Adequate organ function per protocol-defined criteria.
Adequate organ function defined as follows:
Have adequate organ function, defined as:
Adequate organ function (defined by the following parameters):
Adequate organ function defined as follows:
Adequate organ function as defined by and obtained within 28 days of starting treatment:
Adequate organ function, defined as follows:
Adequate organ function within 14 days of study registration (30 days for pulmonary and cardiac) as defined in section 4.5
Poor vital organ function defined as:
Adequate organ function defined as:
Adequate organ function as defined by the following criteria:
Must have adequate organ function defined as:
Adequate organ function per protocol-defined criteria.
Subject has adequate pulmonary function defined as:
Adequate organ function as defined by the following criteria:
Must have adequate organ function, as defined by the following:
Adequate organ function as defined by:
Adequate organ function within 28 days prior to enrollment, as defined by the following criteria:
Adequate organ function as defined below:
Adequate organ function as defined below:
Adequate organ function as defined by all the following criteria:
Patients must have adequate organ function at baseline as defined below: • Adequate liver function (within 7 days of crenolanib commencement), as determined by:
Adequate organ function as defined by the following criteria:
All patients must have adequate organ function defined as:
Has adequate organ function as defined by:
Adequate organ function as defined in the protocol
Has adequate organ function as defined by the following criteria:
Adequate non-hematologic organ system function, defined by:
Have adequate organ function defined by the protocol.:
Patients must have organ function as defined below:
Adequate organ function as defined by study-specific laboratory tests
Adequate organ function, as defined by the following criteria:
Adequate organ function per protocol-defined criteria.
Adequate organ function defined as:
Adequate organ function defined as follows:
Has adequate organ function as defined by protocol defined labs.
Adequate organ function defined as:
Adequate organ function as defined in the protocol
Adequate organ function at baseline as defined below. All laboratory assessments should be performed within 10 days of treatment initiation.
Have adequate organ function, as defined by the study protocol.
Adequate organ function as defined by the following criteria:
Adequate organ function per protocol-defined criteria.
Adequate organ function per protocol-defined criteria.
Adequate organ function per protocol-defined criteria.
Adequate organ function defined as follows:
Adequate organ function as defined below:
Has adequate organ function as defined by protocol
Organ Function Requirements - Subjects must have adequate organ functions as defined below:
Adequate organ function defined as:
Adequate baseline organ function as defined below
Adequate organ function, defined as:
Adequate organ function according to protocol-defined criteria
Adequate end organ function as defined by:
Adequate organ function as defined by the following criteria:
Adequate organ function defined as follows:
Adequate organ function defined as follows:
Adequate organ function defined as follows:
Adequate organ function defined as:
Adequate organ function defined as follows:
Adequate organ function defined as follows:
Adequate organ function as defined below:
Adequate organ function defined as follows:
Adequate organ function defined as below:
Adequate baseline organ function as defined in the protocol.
Adequate organ function as defined below:
Must have adequate organ function as defined by the following screening values (Retesting of borderline screening organ function and treatment with blood transfusions, growth factors etc. will be allowed):
Patients must have adequate organ function, as defined by the following parameter
Adequate organ function as defined by:
Patients must have adequate organ function, as defined by the following parameters:
Patients must have adequate organ function within 14 days prior to registration, as defined below:
Have adequate heart function defined as:
Organ Function Requirements: Subjects must have adequate liver function as defined by:
Organ Function Requirements: Subjects must have adequate liver function as defined by:
Acceptable pre-study organ function during screening defined as:
Subject must have adequate organ function as defined in the protocol.
Adequate end organ function as defined by:
Adequate organ function within 7 days prior to enrollment, as defined by the following criteria:
Adequate organ system function, defined as follows: